nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA7—renal system—muscle cancer	0.0169	0.0739	CbGeAlD
Brinzolamide—CA14—cardiac atrium—muscle cancer	0.0126	0.0551	CbGeAlD
Brinzolamide—CA9—tendon—muscle cancer	0.0116	0.0506	CbGeAlD
Brinzolamide—CA14—tendon—muscle cancer	0.011	0.048	CbGeAlD
Brinzolamide—CA12—renal system—muscle cancer	0.011	0.048	CbGeAlD
Brinzolamide—CA6—head—muscle cancer	0.0109	0.0479	CbGeAlD
Brinzolamide—CA9—testis—muscle cancer	0.00959	0.0419	CbGeAlD
Brinzolamide—CA5B—cardiac atrium—muscle cancer	0.00881	0.0386	CbGeAlD
Brinzolamide—CA1—renal system—muscle cancer	0.00869	0.038	CbGeAlD
Brinzolamide—CA5B—tendon—muscle cancer	0.00768	0.0336	CbGeAlD
Brinzolamide—CA2—embryo—muscle cancer	0.00744	0.0326	CbGeAlD
Brinzolamide—CA12—head—muscle cancer	0.00734	0.0321	CbGeAlD
Brinzolamide—CA5B—vagina—muscle cancer	0.00713	0.0312	CbGeAlD
Brinzolamide—CA4—renal system—muscle cancer	0.00679	0.0297	CbGeAlD
Brinzolamide—CA5B—head—muscle cancer	0.00659	0.0288	CbGeAlD
Brinzolamide—CA1—bone marrow—muscle cancer	0.00657	0.0287	CbGeAlD
Brinzolamide—CA5B—testis—muscle cancer	0.00636	0.0278	CbGeAlD
Brinzolamide—CA4—cardiac atrium—muscle cancer	0.00608	0.0266	CbGeAlD
Brinzolamide—CA2—smooth muscle tissue—muscle cancer	0.00585	0.0256	CbGeAlD
Brinzolamide—CA1—head—muscle cancer	0.00582	0.0254	CbGeAlD
Brinzolamide—CA2—renal system—muscle cancer	0.00563	0.0246	CbGeAlD
Brinzolamide—CA4—tendon—muscle cancer	0.0053	0.0232	CbGeAlD
Brinzolamide—CA4—bone marrow—muscle cancer	0.00514	0.0225	CbGeAlD
Brinzolamide—CA2—cardiac atrium—muscle cancer	0.00504	0.0221	CbGeAlD
Brinzolamide—Urinary tract disorder—Vincristine—muscle cancer	0.00483	0.00626	CcSEcCtD
Brinzolamide—Connective tissue disorder—Vincristine—muscle cancer	0.0048	0.00623	CcSEcCtD
Brinzolamide—Urethral disorder—Vincristine—muscle cancer	0.00479	0.00621	CcSEcCtD
Brinzolamide—Erythema—Dactinomycin—muscle cancer	0.00476	0.00617	CcSEcCtD
Brinzolamide—CA4—head—muscle cancer	0.00455	0.0199	CbGeAlD
Brinzolamide—Cardiac disorder—Vincristine—muscle cancer	0.00454	0.00588	CcSEcCtD
Brinzolamide—Lacrimation increased—Doxorubicin—muscle cancer	0.00444	0.00575	CcSEcCtD
Brinzolamide—Angiopathy—Vincristine—muscle cancer	0.00443	0.00575	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00442	0.00573	CcSEcCtD
Brinzolamide—Infestation NOS—Etoposide—muscle cancer	0.00441	0.00572	CcSEcCtD
Brinzolamide—Infestation—Etoposide—muscle cancer	0.00441	0.00572	CcSEcCtD
Brinzolamide—Mediastinal disorder—Vincristine—muscle cancer	0.0044	0.00571	CcSEcCtD
Brinzolamide—CA2—tendon—muscle cancer	0.0044	0.0192	CbGeAlD
Brinzolamide—CA4—testis—muscle cancer	0.00439	0.0192	CbGeAlD
Brinzolamide—Alopecia—Vincristine—muscle cancer	0.00432	0.0056	CcSEcCtD
Brinzolamide—Malaise—Dactinomycin—muscle cancer	0.00429	0.00557	CcSEcCtD
Brinzolamide—Mental disorder—Vincristine—muscle cancer	0.00428	0.00555	CcSEcCtD
Brinzolamide—CA2—bone marrow—muscle cancer	0.00426	0.0186	CbGeAlD
Brinzolamide—Hepatobiliary disease—Etoposide—muscle cancer	0.00417	0.00541	CcSEcCtD
Brinzolamide—Back pain—Vincristine—muscle cancer	0.00412	0.00533	CcSEcCtD
Brinzolamide—CA2—vagina—muscle cancer	0.00408	0.0178	CbGeAlD
Brinzolamide—Myalgia—Dactinomycin—muscle cancer	0.00405	0.00526	CcSEcCtD
Brinzolamide—Discomfort—Dactinomycin—muscle cancer	0.00401	0.00519	CcSEcCtD
Brinzolamide—Hypoaesthesia—Etoposide—muscle cancer	0.00394	0.00511	CcSEcCtD
Brinzolamide—Urinary tract disorder—Etoposide—muscle cancer	0.00391	0.00507	CcSEcCtD
Brinzolamide—Agitation—Vincristine—muscle cancer	0.00391	0.00507	CcSEcCtD
Brinzolamide—Urethral disorder—Etoposide—muscle cancer	0.00388	0.00503	CcSEcCtD
Brinzolamide—Infection—Dactinomycin—muscle cancer	0.00386	0.005	CcSEcCtD
Brinzolamide—Vertigo—Vincristine—muscle cancer	0.00382	0.00495	CcSEcCtD
Brinzolamide—Dry eye—Doxorubicin—muscle cancer	0.00378	0.0049	CcSEcCtD
Brinzolamide—CA2—head—muscle cancer	0.00377	0.0165	CbGeAlD
Brinzolamide—Oesophagitis—Doxorubicin—muscle cancer	0.00374	0.00484	CcSEcCtD
Brinzolamide—Rash maculo-papular—Doxorubicin—muscle cancer	0.00372	0.00482	CcSEcCtD
Brinzolamide—Eye disorder—Etoposide—muscle cancer	0.0037	0.0048	CcSEcCtD
Brinzolamide—Cardiac disorder—Etoposide—muscle cancer	0.00367	0.00476	CcSEcCtD
Brinzolamide—Hypertension—Vincristine—muscle cancer	0.00367	0.00476	CcSEcCtD
Brinzolamide—CA2—testis—muscle cancer	0.00364	0.0159	CbGeAlD
Brinzolamide—CYP3A4—renal system—muscle cancer	0.00363	0.0159	CbGeAlD
Brinzolamide—Myalgia—Vincristine—muscle cancer	0.00362	0.0047	CcSEcCtD
Brinzolamide—Visual disturbance—Methotrexate—muscle cancer	0.00362	0.00469	CcSEcCtD
Brinzolamide—Angiopathy—Etoposide—muscle cancer	0.00359	0.00466	CcSEcCtD
Brinzolamide—Hypertonia—Doxorubicin—muscle cancer	0.00358	0.00465	CcSEcCtD
Brinzolamide—Immune system disorder—Etoposide—muscle cancer	0.00358	0.00464	CcSEcCtD
Brinzolamide—Mediastinal disorder—Etoposide—muscle cancer	0.00357	0.00463	CcSEcCtD
Brinzolamide—Abnormal vision—Doxorubicin—muscle cancer	0.00357	0.00462	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00354	0.00459	CcSEcCtD
Brinzolamide—Alopecia—Etoposide—muscle cancer	0.0035	0.00453	CcSEcCtD
Brinzolamide—Infection—Vincristine—muscle cancer	0.00345	0.00447	CcSEcCtD
Brinzolamide—Nervous system disorder—Vincristine—muscle cancer	0.0034	0.00441	CcSEcCtD
Brinzolamide—Decreased appetite—Dactinomycin—muscle cancer	0.00338	0.00438	CcSEcCtD
Brinzolamide—Dysgeusia—Etoposide—muscle cancer	0.00337	0.00437	CcSEcCtD
Brinzolamide—Fatigue—Dactinomycin—muscle cancer	0.00335	0.00434	CcSEcCtD
Brinzolamide—Back pain—Etoposide—muscle cancer	0.00333	0.00432	CcSEcCtD
Brinzolamide—Pain—Dactinomycin—muscle cancer	0.00332	0.00431	CcSEcCtD
Brinzolamide—Muscle spasms—Etoposide—muscle cancer	0.00331	0.0043	CcSEcCtD
Brinzolamide—Eye pain—Doxorubicin—muscle cancer	0.00329	0.00426	CcSEcCtD
Brinzolamide—Irritability—Methotrexate—muscle cancer	0.00327	0.00424	CcSEcCtD
Brinzolamide—Hypotension—Vincristine—muscle cancer	0.00324	0.00421	CcSEcCtD
Brinzolamide—Feeling abnormal—Dactinomycin—muscle cancer	0.0032	0.00415	CcSEcCtD
Brinzolamide—Ill-defined disorder—Etoposide—muscle cancer	0.0032	0.00415	CcSEcCtD
Brinzolamide—Liver function test abnormal—Methotrexate—muscle cancer	0.00316	0.0041	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00316	0.0041	CcSEcCtD
Brinzolamide—Insomnia—Vincristine—muscle cancer	0.00314	0.00407	CcSEcCtD
Brinzolamide—Paraesthesia—Vincristine—muscle cancer	0.00312	0.00404	CcSEcCtD
Brinzolamide—Malaise—Etoposide—muscle cancer	0.00311	0.00403	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—muscle cancer	0.0031	0.00402	CcSEcCtD
Brinzolamide—Vertigo—Etoposide—muscle cancer	0.0031	0.00401	CcSEcCtD
Brinzolamide—Decreased appetite—Vincristine—muscle cancer	0.00302	0.00391	CcSEcCtD
Brinzolamide—Cough—Etoposide—muscle cancer	0.00301	0.0039	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.003	0.00389	CcSEcCtD
Brinzolamide—Fatigue—Vincristine—muscle cancer	0.00299	0.00388	CcSEcCtD
Brinzolamide—Hypertension—Etoposide—muscle cancer	0.00298	0.00386	CcSEcCtD
Brinzolamide—Pain—Vincristine—muscle cancer	0.00297	0.00385	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—muscle cancer	0.00297	0.00385	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—muscle cancer	0.00297	0.00385	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—muscle cancer	0.00296	0.00384	CcSEcCtD
Brinzolamide—Chest pain—Etoposide—muscle cancer	0.00293	0.0038	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00291	0.00378	CcSEcCtD
Brinzolamide—Discomfort—Etoposide—muscle cancer	0.0029	0.00376	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—muscle cancer	0.00286	0.00371	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—muscle cancer	0.00284	0.00368	CcSEcCtD
Brinzolamide—Infection—Etoposide—muscle cancer	0.00279	0.00362	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—muscle cancer	0.00279	0.00361	CcSEcCtD
Brinzolamide—Tachycardia—Etoposide—muscle cancer	0.00274	0.00356	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—muscle cancer	0.00274	0.00355	CcSEcCtD
Brinzolamide—Skin disorder—Etoposide—muscle cancer	0.00273	0.00354	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—muscle cancer	0.00273	0.00354	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—muscle cancer	0.00271	0.00351	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—muscle cancer	0.00268	0.00348	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—muscle cancer	0.00266	0.00345	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—muscle cancer	0.00265	0.00344	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—muscle cancer	0.00264	0.00342	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—muscle cancer	0.00264	0.00342	CcSEcCtD
Brinzolamide—Depression—Methotrexate—muscle cancer	0.00263	0.00341	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—muscle cancer	0.00263	0.00341	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—muscle cancer	0.00257	0.00333	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—muscle cancer	0.00257	0.00333	CcSEcCtD
Brinzolamide—Hypersensitivity—Vincristine—muscle cancer	0.00256	0.00332	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—muscle cancer	0.00253	0.00327	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—muscle cancer	0.00251	0.00325	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—muscle cancer	0.0025	0.00324	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—muscle cancer	0.0025	0.00324	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—muscle cancer	0.0025	0.00324	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—muscle cancer	0.00249	0.00323	CcSEcCtD
Brinzolamide—Asthenia—Vincristine—muscle cancer	0.00249	0.00323	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—muscle cancer	0.00247	0.0032	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—muscle cancer	0.00247	0.0032	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—muscle cancer	0.00245	0.00318	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—muscle cancer	0.00244	0.00317	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00243	0.00315	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—muscle cancer	0.00242	0.00314	CcSEcCtD
Brinzolamide—Pain—Etoposide—muscle cancer	0.00241	0.00312	CcSEcCtD
Brinzolamide—Diarrhoea—Vincristine—muscle cancer	0.00238	0.00308	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—muscle cancer	0.00237	0.00307	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—muscle cancer	0.00235	0.00305	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—muscle cancer	0.00234	0.00304	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—muscle cancer	0.00232	0.00301	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—muscle cancer	0.00232	0.003	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—muscle cancer	0.00231	0.00299	CcSEcCtD
Brinzolamide—Dizziness—Vincristine—muscle cancer	0.0023	0.00298	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—muscle cancer	0.00229	0.00297	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—muscle cancer	0.00229	0.00297	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—muscle cancer	0.00229	0.00296	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—muscle cancer	0.00223	0.0029	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—muscle cancer	0.00222	0.00288	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—muscle cancer	0.00222	0.00287	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—muscle cancer	0.00221	0.00287	CcSEcCtD
Brinzolamide—Vomiting—Vincristine—muscle cancer	0.00221	0.00286	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—muscle cancer	0.0022	0.00285	CcSEcCtD
Brinzolamide—Rash—Vincristine—muscle cancer	0.00219	0.00284	CcSEcCtD
Brinzolamide—Dermatitis—Vincristine—muscle cancer	0.00219	0.00284	CcSEcCtD
Brinzolamide—Headache—Vincristine—muscle cancer	0.00218	0.00282	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00216	0.0028	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—muscle cancer	0.00216	0.0028	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—muscle cancer	0.00215	0.00279	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—muscle cancer	0.00215	0.00278	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—muscle cancer	0.00214	0.00278	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—muscle cancer	0.00214	0.00277	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—muscle cancer	0.0021	0.00272	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—muscle cancer	0.00209	0.00271	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—muscle cancer	0.00208	0.00269	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—muscle cancer	0.00207	0.00269	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—muscle cancer	0.00206	0.00268	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—muscle cancer	0.00206	0.00268	CcSEcCtD
Brinzolamide—Nausea—Vincristine—muscle cancer	0.00206	0.00267	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—muscle cancer	0.00206	0.00267	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00204	0.00265	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—muscle cancer	0.00204	0.00264	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.00203	0.00263	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—muscle cancer	0.00202	0.00262	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—muscle cancer	0.00202	0.00262	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—muscle cancer	0.00202	0.00262	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—muscle cancer	0.00202	0.00262	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—muscle cancer	0.00201	0.00261	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—muscle cancer	0.002	0.00259	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—muscle cancer	0.00199	0.00258	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—muscle cancer	0.00198	0.00257	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—muscle cancer	0.00195	0.00252	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—muscle cancer	0.00192	0.00249	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—muscle cancer	0.00192	0.00249	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—muscle cancer	0.00192	0.00248	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—muscle cancer	0.00191	0.00248	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—muscle cancer	0.00191	0.00247	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—muscle cancer	0.00186	0.00241	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—muscle cancer	0.00186	0.00241	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—muscle cancer	0.00186	0.00241	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—muscle cancer	0.00185	0.0024	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—muscle cancer	0.00185	0.0024	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—muscle cancer	0.00185	0.0024	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—muscle cancer	0.00183	0.00238	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—muscle cancer	0.00181	0.00235	CcSEcCtD
Brinzolamide—Cough—Methotrexate—muscle cancer	0.0018	0.00234	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—muscle cancer	0.0018	0.00233	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—muscle cancer	0.00179	0.00232	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—muscle cancer	0.00179	0.00232	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—muscle cancer	0.00179	0.00232	CcSEcCtD
Brinzolamide—Rash—Etoposide—muscle cancer	0.00177	0.0023	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—muscle cancer	0.00177	0.0023	CcSEcCtD
Brinzolamide—Headache—Etoposide—muscle cancer	0.00176	0.00228	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—muscle cancer	0.00176	0.00228	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—muscle cancer	0.00176	0.00228	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—muscle cancer	0.00176	0.00228	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—muscle cancer	0.00176	0.00228	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—muscle cancer	0.00175	0.00227	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—muscle cancer	0.00175	0.00227	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00175	0.00226	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—muscle cancer	0.00174	0.00225	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—muscle cancer	0.00174	0.00225	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—muscle cancer	0.00173	0.00224	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—muscle cancer	0.00172	0.00223	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—muscle cancer	0.00168	0.00218	CcSEcCtD
Brinzolamide—Infection—Methotrexate—muscle cancer	0.00167	0.00217	CcSEcCtD
Brinzolamide—Nausea—Etoposide—muscle cancer	0.00167	0.00217	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00166	0.00215	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—muscle cancer	0.00165	0.00214	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—muscle cancer	0.00164	0.00213	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—muscle cancer	0.00164	0.00212	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—muscle cancer	0.00161	0.00209	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—muscle cancer	0.00161	0.00208	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—muscle cancer	0.00158	0.00205	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—muscle cancer	0.00157	0.00204	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—muscle cancer	0.00156	0.00202	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—muscle cancer	0.00154	0.002	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00153	0.00199	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—muscle cancer	0.00152	0.00198	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—muscle cancer	0.00152	0.00197	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—muscle cancer	0.00152	0.00197	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—muscle cancer	0.00152	0.00197	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—muscle cancer	0.00151	0.00196	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00151	0.00196	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—muscle cancer	0.0015	0.00195	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—muscle cancer	0.0015	0.00195	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—muscle cancer	0.0015	0.00194	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—muscle cancer	0.00149	0.00193	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—muscle cancer	0.00148	0.00192	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—muscle cancer	0.00146	0.0019	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00145	0.00189	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—muscle cancer	0.00145	0.00188	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—muscle cancer	0.00145	0.00188	CcSEcCtD
Brinzolamide—Pain—Methotrexate—muscle cancer	0.00144	0.00187	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—muscle cancer	0.00143	0.00185	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—muscle cancer	0.00142	0.00185	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—muscle cancer	0.00142	0.00184	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—muscle cancer	0.00139	0.0018	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—muscle cancer	0.00136	0.00177	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—muscle cancer	0.00134	0.00173	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00133	0.00172	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—muscle cancer	0.00132	0.00171	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—muscle cancer	0.00131	0.0017	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—muscle cancer	0.0013	0.00169	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—muscle cancer	0.0013	0.00168	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—muscle cancer	0.00128	0.00166	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—muscle cancer	0.00127	0.00164	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00126	0.00163	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—muscle cancer	0.00126	0.00163	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—muscle cancer	0.00125	0.00162	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—muscle cancer	0.00124	0.00161	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—muscle cancer	0.00121	0.00157	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—muscle cancer	0.0012	0.00156	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—muscle cancer	0.00119	0.00155	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—muscle cancer	0.00116	0.0015	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—muscle cancer	0.00115	0.00149	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—muscle cancer	0.00111	0.00144	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—muscle cancer	0.00107	0.00139	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—muscle cancer	0.00107	0.00139	CcSEcCtD
Brinzolamide—Rash—Methotrexate—muscle cancer	0.00106	0.00138	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—muscle cancer	0.00106	0.00138	CcSEcCtD
Brinzolamide—Headache—Methotrexate—muscle cancer	0.00106	0.00137	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—muscle cancer	0.00105	0.00136	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—muscle cancer	0.00103	0.00134	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—muscle cancer	0.001	0.0013	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—muscle cancer	0.000998	0.00129	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—muscle cancer	0.000965	0.00125	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—muscle cancer	0.000928	0.0012	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—muscle cancer	0.00092	0.00119	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—muscle cancer	0.000919	0.00119	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—muscle cancer	0.000914	0.00118	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—muscle cancer	0.000866	0.00112	CcSEcCtD
